AstraZeneca PLC (LON:AZN)
11,968
-80 (-0.66%)
Aug 22, 2025, 7:13 PM BST
AstraZeneca Revenue
AstraZeneca had revenue of $14.46B USD in the quarter ending June 30, 2025, with 11.74% growth. This brings the company's revenue in the last twelve months to $56.50B, up 15.00% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.
Revenue (ttm)
$56.50B
Revenue Growth
+15.00%
P/S Ratio
4.50
Revenue / Employee
$599.16K
Employees
94,300
Market Cap
185.59B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Oxford Nanopore Technologies | 183.19M |
Genus | 671.60M |
AstraZeneca News
- 1 day ago - J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - Benzinga
- 1 day ago - Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service—The World's First At-Home Nasal Spray Flu Vaccine - Business Wire
- 5 days ago - China State Administration for Market Regulation approves sale of FibroGen China to AstraZeneca - Seeking Alpha
- 6 days ago - Scared of needles? AstraZeneca launches FluMist Home nasal spray delivery - The Times of India
- 8 days ago - FLUMIST (Influenza, Vaccine Live, Intranasal), the nation's only nasal spray flu vaccine, now available for home delivery - Benzinga
- 8 days ago - George Soros Exits AstraZeneca PLC, Impacting Portfolio by -3.98% - GuruFocus
- 10 days ago - The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact - PRNewsWire
- 10 days ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga